Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 15 September 2026.
Announcements
291
Total raised
£10.2B
disclosed amounts
The financing was backed by Sompo Light Vortex and existing investors.
"Executing a successful capital raise in this economic environment is a major achievement for Wejo and reflects our investors’, partners’, and directors’ confidence in the Company’s ability to improve business fundamentals as we focus our portfolio of solutions around the traffic and insurance product lines,"
The funding comprises private sector backing alongside a grant from Scottish Enterprise to advance maritime decarbonisation.
"Scotland’s decision to support this project shows that wind technology has the might of a maritime nation behind it. Shipping has a long history of harnessing the power of wind, but digital technologies are allowing us to work towards making zero emission vessels a reality. Smart Green Shipping’s FastRig wing sail technology offers a financially and technically robust solution to help support shipping’s green transition."
Love Ventures led the funding round, which will support global expansion for the rental platform.
"There’s a gap in the market for a property platform that radically transforms renting, that’s also truly aligned with both renters and landlords. Tom and his team have the ambition and understanding to re-shape the customer experience for renters in ways that are long overdue. We’re excited to be working with Residently to help fund their global expansion and create a world leading home brand."
The funding round was backed by Wayra UK, Octopus Ventures, and Macquarie to support the rollout of Raylo Pay.
"There is a clear shift in consumer behaviour and their preference for subscription based payment models. There’s an appetite for more affordable options to purchase great technology and devices. The Raylo team has proven success in delivering on this consumer trend, and we look forward to helping them scale up their platform through our strategic resources and networks."
The pre-IPO financing comes from a cornerstone investor to support affordable mRNA vaccine development and modular manufacturing.
"Normax is on a social mission to redress global healthcare inequity caused by the profiteering pharmaceutical industry. Following the recent €300 million capital commitment in Normax, we plan to deliver research and development of mRNA vaccines for COVID, TB, HIV, and Malaria and deploy modular mRNA Vaccine Factories, ultimately in up to 100 locations. In the event of another public health emergency we are also committed to delivering future mRNA vaccines in 100 days, to help ensure that COVID-19 is the last pandemic we will all suffer through,"
